Cargando…

Antithrombotic therapy after femoropopliteal artery stenting: 12-month results from Japan Postmarketing Surveillance

OBJECTIVE: To investigate the effects of antithrombotic therapy on target lesion revascularisation (TLR) and major adverse cardiovascular and cerebrovascular events (MACCEs) at 12 months after femoropopliteal intervention with second-generation bare metal nitinol stents. METHODS: A total of 277 lesi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kawarada, Osami, Nakai, Michikazu, Nishimura, Kunihiro, Miwa, Hideki, Iwasaki, Yusuke, Kanno, Daitaro, Nakama, Tatsuya, Yamamoto, Yoshito, Ogata, Nobuhiko, Nakamura, Masato, Yasuda, Satoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6454330/ https://www.ncbi.nlm.nih.gov/pubmed/31031828 http://dx.doi.org/10.1136/heartasia-2018-011114

Ejemplares similares

Heterogeneous vascular response after implantation of bare nitinol self-expanding stents in the swine femoropopliteal artery
por: Kawarada, Osami, et al.
Publicado: (2022)

Calcified nodule progression-related stent thrombosis after polymer-based paclitaxel-eluting nitinol stent implantation for femoropopliteal artery
por: Nakama, Tatsuya, et al.
Publicado: (2020)

Viabahn for femoropopliteal in-stent restenosis
por: Al Shammeri, Owayed, et al.
Publicado: (2012)

Angiographic and Intravascular Imaging Findings for Ultrasound Detected Aneurysmal Degeneration Following Polymer Based Paclitaxel Eluting Nitinol Stent Implantation for Femoropopliteal Artery Occlusion
por: Nakama, Tatsuya, et al.
Publicado: (2020)

Treatment of Femoropopliteal Artery In-stent Restenosis
por: Kim, Wonho, et al.
Publicado: (2018)

Emerging Stent and Balloon Technologies in the Femoropopliteal Arteries
por: Pastromas, Georgios, et al.
Publicado: (2014)

Improvement of left ventricular filling and pulmonary artery pressure following unilateral renal artery total occlusion stenting in a patient with recurrent congestive heart failure complicated by renovascular hypertension and renal failure
por: Kawarada, Osami, et al.
Publicado: (2015)

Technique and early results of percutaneous femoropopliteal bypass with stent graft
por: Sarradon, Pierre, et al.
Publicado: (2023)

Prophylactic paclitaxel-eluting stent placement does not improve covered femoropopliteal stent patency()
por: Marples, Rory, et al.
Publicado: (2021)

Trans-stent graft thrombectomy for the treatment of long stent graft thrombosis in the femoropopliteal artery
por: Ozawa, Hirotsugu, et al.
Publicado: (2021)

Swirling Flow and Wall Shear: Evaluating the BioMimics 3D Helical Centerline Stent for the Femoropopliteal Segment
por: Sullivan, Timothy M., et al.
Publicado: (2018)

A Budget Impact Model for Paclitaxel-eluting Stent in Femoropopliteal Disease in France
por: De Cock, Erwin, et al.
Publicado: (2012)

Primary stenting for femoropopliteal peripheral arterial disease: analysis up to 24 months
por: Geiger, Martin Andreas, et al.
Publicado: (2019)

Histological Evaluation of Self-Expandable Interwoven Stent After Implantation in the Femoropopliteal Artery
por: Hata, Yosuke, et al.
Publicado: (2020)

Endovascular Treatment and Outcomes for Femoropopliteal In-Stent Restenosis: Insights from the XLPAD Registry
por: Vu, Michael H., et al.
Publicado: (2022)

Meta-analysis of outcomes from drug-eluting stent implantation in femoropopliteal arteries
por: Li, Mingxuan, et al.
Publicado: (2023)

A better effect of cilostazol for reducing in-stent restenosis after femoropopliteal artery stent placement in comparison with ticlopidine
por: Ikushima, Ichiro, et al.
Publicado: (2011)

Assessment of Mortality and Factors Affecting Outcome of Use of Paclitaxel-Coated Stents and Bare Metal Stents in Femoropopliteal PAD
por: Falkowski, Aleksander, et al.
Publicado: (2020)

Retrospective multicenter registry for endovascular treatment with newer devices in over 25‐cm femoropopliteal artery disease: A retrospective observational study
por: Horie, Kazunori, et al.
Publicado: (2022)

Substent Anchor Technique for Recanalisation of a Full Metal Jacket Femoropopliteal In-Stent Occlusion
por: Testi, Gabriele, et al.
Publicado: (2018)

Comparison of Balloon Angioplasty and Stent Implantation for Femoropopliteal Disease According to Patient and Lesion Subgroup
por: Kobayashi, Norihiro, et al.
Publicado: (2019)

Drug-Coated Balloon for the Treatment of Femoropopliteal Tosaka Class III In-stent Restenosis Lesions
por: Zhang, Bihui, et al.
Publicado: (2021)

Effect of balloon pre-dilation on performance of self-expandable nitinol stent in femoropopliteal artery
por: He, Ran, et al.
Publicado: (2022)

Femoropopliteal Artery Stent Fracture with Recurrent In-Stent Reocclusion and Aneurysm Formation: Successful Treatment with Self-Expandable Viabahn Endoprosthesis
por: Lee, Yong-Joon, et al.
Publicado: (2015)

Impact of Postoperative Lumen Gain on the Reduction of Restenosis Risk after Endovascular Treatment using Drug-coated Balloon for Femoropopliteal Lesions Assessed by Intravascular Ultrasound
por: Horie, Kazunori, et al.
Publicado: (2023)

Evaluation of the 4-French Pulsar-18 Self-expanding Nitinol Stent in Long Femoropopliteal Lesions
por: Lichtenberg, Michael, et al.
Publicado: (2015)

Supera self-expanding stents for endovascular treatment of femoropopliteal disease: a review of the clinical evidence
por: Bishu, Kalkidan, et al.
Publicado: (2015)

Impact of number of run-off vessels on interwoven nitinol mesh stents patency in the femoropopliteal segment
por: Rigatelli, Gianluca, et al.
Publicado: (2020)

Differential efficacy between stenting and plain balloon angioplasty for femoropopliteal disease with or without total occlusion
por: Chae, In-Ho, et al.
Publicado: (2020)

Long-term clinical effectiveness of a drug-coated balloon for in-stent restenosis in Femoropopliteal lesions
por: Horie, Kazunori, et al.
Publicado: (2021)

Clinical outcome of drug-coated balloons in patients with femoropopliteal chronic total occlusive lesions: results from the multicenter EAGLE study
por: Hayakawa, Naoki, et al.
Publicado: (2022)

Cardiac function response to stenting in atherosclerotic renal artery disease with and without heart failure: results from the Carmel study
por: Kawarada, Osami, et al.
Publicado: (2019)

Algorithm of Femoropopliteal Endovascular Treatment
por: Dubosq, Maxime, et al.
Publicado: (2022)

Coronary and peripheral artery aneurysms in a patient with cutaneous T-cell lymphoma
por: Yasutake, Hideki, et al.
Publicado: (2017)

Mechanical rotational thrombectomy in long femoropopliteal artery and stent occlusion in COVID-19 patient: Case report
por: Dinoto, E., et al.
Publicado: (2021)

Ten-Year Clinical Follow-Up Following Bare-Nitinol Stent Implantation for Femoropopliteal Artery Disease
por: Soga, Yoshimitsu, et al.
Publicado: (2022)

Long-Term Results of Endovascular Treatment with Nitinol Stents for Femoropopliteal TASC II C and D Lesions
por: Kluckner, Michaela, et al.
Publicado: (2022)

Drug‐Coated Balloon and Drug‐Eluting Stent Safety in Patients With Femoropopliteal and Severe Chronic Kidney Disease
por: Hanna, Jonathan, et al.
Publicado: (2023)

Impact of postprocedural minimum lumen area on clinical outcome after femoropopliteal drug-eluting stent implantation
por: Haraguchi, Takuya, et al.
Publicado: (2023)

Zilver PTX Post-market Surveillance Study of Paclitaxel-Eluting Stents for Treating Femoropopliteal Artery Disease in Japan: 2-Year Results
por: Kichikawa, Kimihiko, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ev4vu3l8k47u1hcjgrfp07ard9